The majority of atopic dermatitis (AD) patients with hand and/or foot (H&F) involvement experienced clearance over 12 months of treatment with ADBRY(R) (tralokinumab-ldrm)/ADTRALZA(R) (tralokinumab).1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results